BASEL TOUBAN to Cell Line, Tumor
This is a "connection" page, showing publications BASEL TOUBAN has written about Cell Line, Tumor.
Connection Strength
0.029
-
Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib. Clin Cancer Res. 2012 May 01; 18(9):2704-14.
Score: 0.015
-
Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer. Clin Cancer Res. 2010 Aug 15; 16(16):4165-77.
Score: 0.013